Article info
PDFReview
Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now
- Correspondence to Dr Ricky A Sharma, Cancer Research UK-Medical Research Council Gray Institute for Radiation Oncology and Biology, Oncology Department, Old Road Research Campus Building, OX3 7DQ, UK; ricky.sharma{at}oncology.ox.ac.uk
Citation
Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is now
Publication history
- Accepted May 17, 2012
- First published June 25, 2012.
Online issue publication
October 25, 2017
Article Versions
- You are viewing the most recent version of this article.
- Previous version (25 October 2017).
- latest version (25 October 2017).
- latest version (25 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.